Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.
Haller H; Ito S; Izzo JL Jr; Januszewicz A; Katayama S; Menne J; Mimran A; Rabelink TJ; Ritz E; Ruilope LM; Rump LC; Viberti G; The New England Journal Of Medicine, 2011, vol. 364, issue 10, p 907, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation